SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-075296
Filing Date
2024-06-20
Accepted
2024-06-20 07:01:20
Documents
12
Period of Report
2024-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evok-20240620.htm   iXBRL 8-K 46122
2 EX-4.1 evok-ex4_1.htm EX-4.1 36603
  Complete submission text file 0000950170-24-075296.txt   197758

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240620.xsd EX-101.SCH 23902
15 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240620_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 241054029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)